Prof Eric Vibert is an expert in Digestive surgery at Hôpital Paul-Brousse (France). As of November 2026, ScienceLeadR ranks Eric Vibert in the top 1% of experts worldwide for Liver Neoplasms, Tissue Transplantation and Carcinoma. Eric Vibert has authored 467 publications, the most recent in 2026, and is an investigator in 12 clinical trials, 2 of them ongoing. SLR score: 1,451 (community average: 125). How the SLR is computed.

LeadR Profile

Prof Eric Vibert Hôpital Paul-Brousse France
1 451 ScienceLeadR Reputation 1451
Network Map

Digestive surgery

Subspecialties: Surgery - Hepatology - Transplantation

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Expert Rankings

Top experts on the MeSH terms this expert works on

Short Biography

Prof. Eric VIBERT, MD, PhD, is 52-year-old academic surgeon at AP-HP specialized in the liver surgery and transplantation at Paul Brousse Hospital, Villejuif, where he works 2007. He had more than 130 International Congress Communication and 30 invited plenary conferences in International meetings. With a H-index of 53, he had 253 publications on liver diseases (See https://www.ncbi.nlm.nih.gov/pubmed/?term=vibert+e). He graduated in Innovative treatment of post-hepatectomy liver failure, U-PSUD in 2012, when he also received his habilitation to direct research. E.Vibert is currently full Professor PU-PH and researcher in surgical innovation (Paris Saclay Univ and INSERM U1193), connecting people arising from different worlds, especially engineers and surgeons to reinvent practices in surgery. From 2019, he is chairman of large consortium including Paris-Saclay Univ, Mines Telecom School and AP-HP called BOPA for enhanced Operating room ((www.chaire-bopa.fr) that involved surgeon, anesthesiologist, surgical nurse and mathematician, engineers, anthropologist to improve safety in operating room. BOPA is a large public/private consortium that it funded by AP-HP and IMT Foundation using sponsorship from Orange, Medtronics, Relyens, Boston Scientific Foundation, Richard Wolf, Getinge, Caresyntax, J&J and Fujifilm. From 2022, he is Heath Ambassador in France 2030 Program. In 2023, he had started a strong partnership between Paul Brousse Hospital & Paris Saclay Cancer Cluster in the fied of liver and pancreatic cancer. He chair also with Nicolas Castoldi, Campus BOPEX, a "Tiers Lieux" dedicated to Digital Experimentation in Operating Room created in Heath-France2030 program. He is the author of the book “Droit à l’Erreur, Devoir de Transparence” Ed Observatoire. Paris 2021.

Organizations

Career arc: 2002 - 2026

Source: PubMed

Hôpital Paul-Brousse

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 467

Citations

Citations: 11 628 1st author: 36 Last author: 80 Unique author: 3


Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Correction to: Implementation of audiovisual recording in the operating room: a nationwide survey of stakeholder perspectives in France.
PMID 42834387 — operating rooms, video recording
Patient Saf Surg20260
Surg-STAMPS: Synchronized Temporal Analytics of Motion, Physiology, and Speech in Surgery.
PMID 42585044 — medical informatics, physiology, communication, work, environment, speech
IEEE J Biomed Health Inform20260
Is Cytoreductive surgery for unresectable colorectal liver metastases able to improve patient outcome? Results of a pilot prospective study.
PMID 42561547 — pilots, cytoreduction surgical procedures, drug therapy, liver, hepatectomy, neoplasm metastasis, prospective studies, chemotherapy
Cancer Treat Rev20260
Right (H145678) and Left (H123458) 6-Segmentectomies for Malignant Liver Tumors: A Retrospective Analysis of 237 Cases Using Contemporary Surgery Quality Indicators.
PMID 42522084 — neoplasms, mastectomy, segmental, liver, general surgery, cholangiocarcinoma, survival rate
Ann Surg20260
Does Surgical Approach Influence Benchmark Attainment in Intrahepatic Cholangiocarcinoma?
PMID 42496491 — mortality, lymph node excision, neoplasms, liver, general surgery, cholangiocarcinoma, intrahepatic cholangiocarcinoma
World J Surg20260

Clinical Studies 12

Sources: ClinicalTrials, EU CTIS

Synthesis

Principal Investigator: 2

By phase:

N/A 10
Phase 1/Phase 2 1
Phase 2 1

By status:

Completed 5
Unknown 4
Active not recruiting 1
Not yet recruiting 1
Recruiting 1

By type:

Interventional 10
Observational 2

By Monocentric/Multicentric:

monocentric 8
multicentric2to4 1
multicentric5to9 0
multicentricup10 3

Main Topics

Cohort/Consortium Investigators 7

Ongoing Clinical Trials

2 ongoing trials started since 2021, where this expert is an investigator

Source: ClinicalTrials

Study Phase Status Start
Resection And Partial LIver Transplantation With Delayed Hepatectomy for Hepatocellular Carcinoma
NCT05971628 — liver transplantation, carcinoma, hepatocellular, liver, hepatectomy, transplantation, carcinoma
N/ANot yet recruiting2023
Hepatic and Systemic Hemodynamic Modeling During Liver Surgery
NCT05339984 — liver diseases, hypertension, liver transplantation, neoplasms, portal vein, liver, hepatectomy, hypertension, portal, veins, transplantation, hemodynamics
N/ARecruiting2023

LeadR Networks

Main global connection map